Norah Terrault, MD, MPH

Norah Terrault, MD, MPH

Assistant Professor, Department of Medicine (Gastroenterology), UCSF

Phone: (415) 353-2318 (appts)
Box 0538, UCSF
San Francisco, CA 94143-0538

UCSF Profiles | Physician Referral Directory

Cancer Center Membership

Associate Member » Non-aligned


University of Alberta, MD, 1984-87
University of Toronto, FRCPC, 1988-92, Internal Medicine
University of Toronto, FRCPC, 1992-94, Gastroenterology
University of California, Berkeley, MPH, 1996-97, Epidemiology

Professional Experience

  • 1987-88 Comprehensive internship, University of Toronto
  • 1988-91
    Residency in Internal Medicine, University of Toronto
  • 1991-93
    Residency in Gastroenterology, University of Toronto
  • 1993-94
    Clinical Fellowship, University of Toronto
  • 1994-97
    Research Fellowship, University of California San Francisco
  • 1997-2002
    Adjunct Assistant Professor, Dept. of Medicine/Gastroenterology, University of California San Francisco
  • 2002-present
    Assistant Professor, Dept. of Medicine/Gastroenterology, University of California San Francisco

Honors & Awards

  • 1991
    Dr. D.H. Cowan, University of Toronto Teaching Award
  • 1992
    CAG Residents' Presentation Award
  • 1994
    CASL Presentation Award
  • 1994-96
    Canadian Liver Foundation Fellowship Award
  • 1996
    Canadian Liver Foundation Fellowship Award (declined)
  • 1996
    Medical Research Council of Canada Fellowship Award (declined)
  • 1996-8
    Dr. Saul Krugman Career Development Award
  • 1997-9
    Jan Albrecht Career Development Award

Selected Publications

  1. Terrault NA, Hassanein TI. Management of the patient with SVR. J Hepatol. 2016 Oct; 65(1 Suppl):S120-9.
    View on PubMed
  2. Terrault NA. Real-World Experiences with Tenofovir Disoproxil Fumarate: Is this the "B-Ticket"? Dig Dis Sci. 2016 Oct; 61(10):2770-2.
    View on PubMed
  3. Campos-Varela I, Dodge JL, Stock PG, Terrault NA. Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus. Clin Transplant. 2016 Sep; 30(9):1140-5.
    View on PubMed
  4. Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N.  Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant. Ann Hepatol. 2016 Jul-Aug; 15(4):545-9.
    View on PubMed
  5. Nathanson MH, Terrault N. Hepatitis B surface antigen loss: Not all that we hoped it would be. Hepatology. 2016 Aug; 64(2):328-9.
    View on PubMed
  6. Giard JM, Terrault NA. Women with Cirrhosis: Prevalence, Natural History, and Management. Gastroenterol Clin North Am. 2016 Jun; 45(2):345-58.
    View on PubMed
  7. Chen T, Terrault N. Treatment of chronic hepatitis C in patients with cirrhosis. Curr Opin Gastroenterol. 2016 May; 32(3):143-51.
    View on PubMed
  8. Campos-Varela I, Moreno A, Morbey A, Guaraldi G, Hasson H, Bhamidimarri KR, Castells L, Grewal P, Baños I, Bellot P, Brainard DM, McHutchison JG, Terrault NA. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy. Aliment Pharmacol Ther. 2016 Jun; 43(12):1319-29.
    View on PubMed
  9. Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge J, Roberts JP, Terrault NA, Feng S. Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation. Liver Int. 2016 Apr; 36(4):611.
    View on PubMed
  10. Terrault NA. The changing 'face' of wait-listed patients in the USA. Curr Opin Organ Transplant. 2016 Apr; 21(2):89-90.
    View on PubMed
  11. Chen T, Terrault NA. Perspectives on treating hepatitis C infection in the liver transplantation setting. Curr Opin Organ Transplant. 2016 Apr; 21(2):111-9.
    View on PubMed
  12. Soriano V, Young B, Terrault N. Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016. AIDS Rev. 2016 Apr-Jun; 18(2):81-8.
    View on PubMed
  13. Saxena V, Koraishy FM, Sise ME, Lim JK, Schmidt M, Chung RT, Liapakis A, Nelson DR, Fried MW, Terrault NA. Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function. Liver Int. 2016 Jun; 36(6):807-16.
    View on PubMed
  14. Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol. 2016 May; 111(5):658-64.
    View on PubMed
  15. Saxena V, Terrault NA. Treatment of Hepatitis C Infection in Renal Transplant Recipients: The Long Wait Is Over. Am J Transplant. 2016 May; 16(5):1345-7.
    View on PubMed
  16. Hameed B, Terrault N. Emerging Therapies for Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2016 May; 20(2):365-85.
    View on PubMed
  17. Brown RS, O'Leary JG, Reddy KR, Kuo A, Morelli GJ, Burton JR, Stravitz RT, Durand C, Di Bisceglie AM, Kwo P, Frenette CT, Stewart TG, Nelson DR, Fried MW, Terrault NA. Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network. Liver Transpl. 2016 Jan; 22(1):24-33.
    View on PubMed
  18. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM. Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology. 2016 Mar; 150(3):684-695.e5.
    View on PubMed
  19. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016 Jan; 63(1):261-83.
    View on PubMed
  20. Zoulim F, Liang TJ, Gerbes AL, Aghemo A, Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK, Terrault NA, Wiktor S. Hepatitis C virus treatment in the real world: optimising treatment and access to therapies. Gut. 2015 Nov; 64(11):1824-33.
    View on PubMed

Go to UCSF Profiles, powered by CTSI